Australia Infusion Therapy Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Australia Infusion Therapy Market Overview

The market is growing steadily as healthcare providers increasingly rely on advanced infusion systems to deliver medications, nutrition and vital fluids safely and efficiently. Rising chronic illnesses, expanding cancer treatments and the growing shift toward home-based care continue to strengthen the demand for dependable infusion therapy services. Strategic investments, improved manufacturing capacity and stronger safety standards further support market expansion by reducing supply risks and enhancing treatment quality. With ongoing technological upgrades, supportive government initiatives and widening clinical applications, the market is well-positioned for sustained growth over the forecast period.

Australia Infusion Therapy Market Growth Drivers

Rising Chronic Disease Burden to Propel the Market Value

A steady rise in long-term health issues is expected to be a strong growth driver in the market, as it continually expands the number of people who need ongoing and reliable treatment support. This upward shift means more individuals require therapies that deliver medications and nutrients directly into the body, making infusion treatment a vital part of routine care. For instance, in 2022, the Australian Bureau of Statistics (ABS) noted that 50% of Australians had one or more chronic conditions, increasing from 47% in 2017–18. This steady climb in chronic illnesses naturally strengthens the demand for infusion-based therapies, encouraging hospitals and care providers to improve their service capacity and ensure uninterrupted access to essential treatments.

Strategic Investments to Boost the Australia Infusion Therapy Market Expansion

Strong financial backing is expected to be a growth driver in the market, as major investments often determine how quickly healthcare services can strengthen and scale. For instance, in March 2025, Baxter Healthcare announced through its official newsroom that the company, along with the Australian Government, invested AUD 40 million to expand Australia’s local IV-fluid manufacturing capacity. This initiative improves supply stability and reduces the risk of future shortages, giving hospitals and clinics greater confidence in their treatment capabilities. Such long-term support naturally boosts demand for advanced infusion pumps, supporting steady market expansion.

Australia Infusion Therapy Market Trends

The market is witnessing several emerging trends, including a stronger focus on quality and safety standards and a notable shift toward expanding onshore IV-fluid manufacturing to ensure long-term supply security.

Growing Focus on Quality and Safety is Likely to Elevate the Australia Infusion Therapy Market Demand

Strong focus on quality and safety standards in infusion care is becoming a major trend within the market. For example, in April 2025, ICU Medical announced that its Infusion Assessment Program earned the Infusion Nurses Society (INS) Seal of Approval, giving healthcare facilities access to a no cost, expert-led audit that helps improve IV therapy safety, efficiency and compliance. This shift toward more standardized and evidence-based infusion practices enables hospitals and clinics to optimize their processes, ultimately strengthening the demand for dependable infusion therapy services across Australia.

Increasing Onshore IV Fluid Production to Accelerate Australia Infusion Therapy Market Demand

Strong national efforts to secure local manufacturing capacity in Australia are shaping a new trend in the infusion therapy sector. For example, in March 2025, the Australian Government announced a plan to expand onshore production of critical IV fluids by investing AUD 20 million, matched by Baxter Healthcare, to lift output to 80 million units annually from 2027 onward. This move strengthens supply security, ensures reliable availability of intravenous solutions, and encourages clinics and hospitals to scale up infusion infrastructure. As a result, demand for essential IV fluid supplies is expected to grow, supporting long term market expansion across Australia.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Australia Infusion Therapy Market Share

Cancer Expected to Dominate the Market Share by Indication

Cancer is anticipated to lead this segment, as it consistently requires frequent and controlled infusion treatments, including chemotherapy, immunotherapy and supportive care. This high dependency naturally increases the demand for advanced infusion solutions and pushes hospitals and clinics to strengthen their infusion infrastructure. As more patients rely on long-term cancer care, the market continues to expand, creating steady opportunities for service providers and equipment manufacturers. This rising usage also boosts interest in reliable infusion therapy equipment, supporting overall market growth. Other segments include gastrointestinal disorders, congestive heart failure, rheumatoid arthritis, hemophilia, immune deficiencies and many more.

Leading Players in the Australia Infusion Therapy Market

Other key players include Baxter AG, Terumo Medical Corporation, Fresenius Kabi, and Cardinal Health.

Australia Infusion Therapy Market Segmentation

Key Questions Answered in the Australia Infusion Therapy Market Report

• What was the Australia infusion therapy market value in 2025?
• What is the Australia infusion therapy market forecast outlook for 2026-2035?
• What is the market breakup based on product?
• What is the market segmentation based on indication?
• What is the market breakup based on therapy type?
• What is the market breakup based on the end user?
• What are the major factors aiding the Australia infusion therapy market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major Australia infusion therapy market trends?
• Which product is expected to dominate the market segment?
• Which indication is projected to lead the market segment?
• Which therapy type is likely to dominate the market segment?
• Which end user is likely to dominate the market segment?
• Who are the key players involved in the Australia infusion therapy market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?